Its monotherapy and in combination with paclitaxel have entered the clinical trial stage.113 Lovastatin, simvastatin, and atorvastatin are specific HMGCR inhibitors that have been FDA approved to lower cholesterol.114,115 Targeting these enzymes may be a therapeutic alternative for MYC-driven cancers. This evidence concerns the gene MYC and cancer.